Regeneron Pharmaceuticals (REGN) Capital Expenditures (2009 - 2026)
Regeneron Pharmaceuticals' Capital Expenditures was $240.2 million in Q2 2026, up 9.7% from $219 million a year earlier and up 4.2% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Capital Expenditures (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regeneron Pharmaceuticals' Capital Expenditures was $920.9 million through Jun 30, 2026, up 3.5% year-over-year; for FY2025, it was $898.4 million, up 18.9% from FY2024.
- Capital Expenditures has now increased for four consecutive years, with a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $755.9 million in FY2024 (+5.2%), $718.6 million in FY2023 (+21.8%), $590.1 million in FY2022 (+6.9%) and $551.9 million in FY2021 (-10.2%).
- Quarterly Capital Expenditures has moved between $113 million (Q2 2023) and $251.4 million (Q4 2023) over five years.
- Compared with a year earlier, Capital Expenditures has increased for three straight quarters, with growth averaging 15.9% over the last eight quarters.
- The best year-over-year quarter for Capital Expenditures over five years was Q1 2025 (growth of 71.2%); the worst was Q2 2023 (a decline of 26.4%).
- Per Business Quant data, REGN's Capital Expenditures in the three quarters before Q2 2026 was $230.6 million (Q1 2026), $248.7 million (Q4 2025) and $201.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 240.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240.20 Mn |
| Mar 31, 2026 | 230.60 Mn |
| Dec 31, 2025 | 248.70 Mn |
| Sep 30, 2025 | 201.40 Mn |
| Jun 30, 2025 | 219.00 Mn |
| Mar 31, 2025 | 229.30 Mn |
| Dec 31, 2024 | 199.60 Mn |
| Sep 30, 2024 | 241.90 Mn |
| Jun 30, 2024 | 180.50 Mn |
| Mar 31, 2024 | 133.90 Mn |
| Dec 31, 2023 | 251.40 Mn |
| Sep 30, 2023 | 176.00 Mn |
| Jun 30, 2023 | 113.00 Mn |
| Mar 31, 2023 | 178.20 Mn |
| Dec 31, 2022 | 152.20 Mn |
| Sep 30, 2022 | 142.50 Mn |
| Jun 30, 2022 | 153.60 Mn |
| Mar 31, 2022 | 141.80 Mn |
| Dec 31, 2021 | 154.90 Mn |
| Sep 30, 2021 | 133.20 Mn |
API Access
Regeneron Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();